Vincent Medical Holdings Limited (1612) AI Stock Analysis

• Market Cap: HK$431.20M
• Dividend Yield: 5%
• Average Volume (3M): 1.07M
• Price to Earnings (P/E): 6.1
• Beta (1Y): 0.50
• Revenue Growth: 11.56%
• EPS Growth: 21.20%
• Country: HK
• Employees: 1,328
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Devices
• EPS (TTM): 0.06
• Shares Outstanding: 653,336,300
• 10 Day Avg. Volume: 810,800
• 30 Day Avg. Volume: 1,068,133
• PEG Ratio: 0.56
• Price to Book (P/B): 0.71
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 31.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: HK$0.50 ▼(-24.24%Downside)

Vincent Medical Holdings Limited's overall stock score reflects a combination of strong financial performance and attractive valuation metrics. The company's solid equity base and low leverage indicate financial stability, while its appealing dividend yield and low P/E ratio suggest potential undervaluation. However, technical indicators show overbought conditions, which could lead to short-term volatility.

Vincent Medical Holdings Limited Business Overview & Revenue Model

Company Description

Vincent Medical Holdings Limited (1612) is a company engaged in the design, development, and manufacturing of medical devices and equipment. The company primarily operates in the healthcare sector, providing a range of medical products, including respiratory devices, anesthesia systems, and orthopedic rehabilitation products. Vincent Medical Holdings Limited serves a global market, supplying its products to hospitals, clinics, and other healthcare facilities.

How the Company Makes Money

Vincent Medical Holdings Limited generates revenue through the sale of its medical devices and equipment. The company's key revenue streams include product sales in respiratory care, anesthesia, and orthopedic rehabilitation. Vincent Medical Holdings Limited collaborates with various healthcare institutions and distributors to expand its market reach and enhance its product offerings. Additionally, the company invests in research and development to innovate and maintain a competitive edge in the medical device industry. Strategic partnerships and a focus on quality and compliance with international standards also contribute to the company's earnings.

Vincent Medical Holdings Limited Financial Statement Overview

Summary

Vincent Medical Holdings Limited shows strong revenue growth and solid equity positioning, reflective of its potential in the medical devices industry. However, cash flow management and income volatility remain areas for improvement. Despite these challenges, the company's low leverage and improving profitability metrics suggest a stable financial foundation with room for growth.

Income Statement

Vincent Medical Holdings Limited demonstrated a positive revenue growth rate of approximately 11.56% for 2024 compared to 2023. The gross profit margin for 2024 was approximately 32.48%, indicating healthy profitability, although the net profit margin was lower at about 8.64%. The EBIT margin was approximately 9.95%, and the EBITDA margin was 12.49%, showing reasonable operational efficiency. However, past fluctuations in EBIT and net income suggest some volatility.

Balance Sheet

The company maintains a solid equity base with an equity ratio of approximately 62.93% in 2024. The debt-to-equity ratio is relatively low at about 0.17, suggesting a conservative leverage approach. Return on equity improved to approximately 11.95% in 2024, indicating good returns on shareholder investment, although past years showed significant swings.

Cash Flow

The company's free cash flow was positive in 2023 but declined to zero in 2024, indicating potential challenges in cash generation. The operating cash flow to net income ratio was zero in 2024, highlighting a need for improvement in converting income to cash. Historical free cash flow growth was volatile, reflecting the need for better cash flow management.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	800.96M	717.97M	629.24M	777.72M	1.16B
Gross Profit	259.99M	222.59M	147.83M	243.83M	478.79M
EBITDA	100.00M	104.43M	28.29M	119.52M	334.17M
Net Income	69.17M	57.27M	-17.40M	60.70M	216.87M
Balance Sheet
Total Assets	919.68M	786.61M	726.70M	846.15M	946.87M
Cash, Cash Equivalents and Short-Term Investments	173.44M	175.78M	159.34M	173.17M	169.07M
Total Debt	99.65M	37.38M	60.39M	62.96M	84.69M
Total Liabilities	336.33M	243.52M	228.09M	245.72M	341.69M
Stockholders Equity	578.55M	541.84M	498.01M	598.36M	611.56M
Cash Flow
Free Cash Flow	-26.52M	61.28M	57.67M	94.48M	142.19M
Operating Cash Flow	73.48M	124.97M	76.27M	119.43M	204.77M
Investing Cash Flow	-98.81M	-62.37M	-18.61M	-20.69M	-132.19M
Financing Cash Flow	26.39M	-45.37M	-67.84M	-101.16M	10.13M

Vincent Medical Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.66
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1612, the sentiment is Positive. The current price of 0.66 is above the 20-day moving average (MA) of 0.60, above the 50-day MA of 0.49, and above the 200-day MA of 0.42, indicating a bullish trend. The MACD of 0.05 indicates Positive momentum. The RSI at 78.46 is Negative, neither overbought nor oversold. The STOCH value of 81.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1612.

Vincent Medical Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1612	68 Neutral	HK$431.20M	6.14	12.35%	5.00%	11.56%	21.20%
6118	54 Neutral	HK$784.25M	45.00	2.06%	―	-16.75%	―
2216	54 Neutral	HK$1.45B	―	-8.64%	―	-20.99%	45.74%
Sector *	52 Neutral	$7.61B	0.10	-63.03%	2.08%	16.34%	0.32%
2393	51 Neutral	HK$323.82M	0.32	1417.08%	―	-20.01%	―
2170	49 Neutral	HK$768.61M	―	-18.64%	―	41.62%	-22.27%
2500	46 Neutral	HK$1.27B	―	-27.82%	―	-6.12%	0.43%

Vincent Medical Holdings Limited Corporate Events

Vincent Medical Holdings Announces Significant Profit Increase for H1 2025

Vincent Medical Holdings Limited has issued a positive profit alert, indicating an expected unaudited consolidated profit of at least HK$50.0 million for the first half of 2025, marking a significant increase of over 50% compared to the same period in 2024. This growth is attributed to increased sales orders in the imaging disposable products segment and improved gross profit margins due to economies of scale and operational efficiency. The final unaudited interim results are still being finalized, and stakeholders are advised to exercise caution when dealing with the company’s shares.

Vincent Medical Holdings Announces Successful AGM Resolutions

Vincent Medical Holdings Limited announced the successful passing of all proposed ordinary resolutions during its Annual General Meeting held on May 21, 2025. Key resolutions included the adoption of the company’s financial statements, approval of a final dividend, re-election of directors, and granting of mandates for share issuance and repurchase. The results indicate strong shareholder support, with all resolutions receiving more than 50% of the votes in favor, reflecting confidence in the company’s governance and strategic direction.